What Insulet's 8-K filings say: 9 filings, latest Sep 21, 2026
Insulet filed its latest 8-K with the SEC on Sep 21, 2026. It discusses debt refinancing and material contract.
Public (PODD)Medical Equipment Manufacturing1,001 to 5,000 employeesinsulet.comLinkedIn
- Filed
- Sep 21, 2026
- Filings
- 9
- Signals
- 28
8-K · latest 10
What Insulet's 8-K filings say
- SEC EDGAR
8-K
Filed · 2 signals
Insulet refinances $475M loan and increases revolving credit facility by $250M to $750M.
The company has secured improved credit terms, including a lower interest rate, and significantly increased its available liquidity with a new $750M undrawn revolving credit facility.
$750M
Total new revolving credit facility available for working capital and general corporate purposes
25%
Reduction in interest rate margin on new term loans
Morgan Stanley Senior Funding, Inc.Wachtell, Lipton, Rosen & Katz
- SEC EDGAR
8-K
Filed · 3 signals
Insulet Board members Timothy Scannell and Michael Minogue resign effective September 2026
The departure of two long-serving board members, including a recent Chairman of 7 years, creates a significant change in governance.
The departure of two experienced board members, Timothy Scannell (12 years service, 7 as Chairman) and Michael Minogue (9 years service), creates a significant governance shift.
Insulet Corp sees departure of two long-serving board members in September 2026
The departure of two experienced board members, including a former Chairman, creates vacancies and a potential shift in governance and long-term strategy.
- SEC EDGAR
8-K
Filed · 3 signals
Insulet appoints former IDEXX CEO Jonathan Mazelsky to Board of Directors, effective July 1, 2026.
The appointment of a new director with extensive leadership experience in medical devices and healthcare technology (IDEXX, Philips, Agilent) may influence corporate strategy, technology investments, and M&A.
- SEC EDGAR
8-K
Filed · 5 signals
Insulet to incur up to $50M in 2026 for second Omnipod medical device correction.
The company is executing a voluntary correction for 7 million Omnipod units due to a manufacturing defect, its second such action in 2026.
$50M
expected costs associated with voluntary medical device correction
Insulet to incur up to $50M in costs from medical device correction due to manufacturing issue.
A recurring manufacturing quality issue at its Acton, MA facility has led to a second product correction, creating a significant financial liability.
$50M
Expected costs associated with voluntary medical device correction
Insulet reveals second manufacturing control failure at its Acton, MA facility in 2026.
A second medical device correction related to the same type of manufacturing issue ('cannula handling') indicates a systemic weakness in quality control.
Insulet faces recurring manufacturing process failure at its Acton, MA facility.
The company identified a second manufacturing process failure related to "cannula handling" at its Acton, MA facility, leading to a major product correction.
$50M
Costs resulting from the manufacturing issue and subsequent product correction.
- SEC EDGAR
8-K
Filed · 4 signals
A voluntary medical device correction has escalated with the FDA reporting 476 serious injuries, far exceeding the company's 29 confirmed events.
Earlier 8-K filings
Showing 10 of 28 filing signals. The Signal API returns all of them.
Get them with one API callSignal API · MCP
Track Insulet with the Signal API
One POST /v1/companies/enrich call with insulet.com returns Insulet 8-K signals (sec-8k), each with its source. Or ask Claude through MCP.
2 credits per signal returned; zero-result calls are free. Endpoint reference
curl -X POST https://signals.autobound.ai/v1/companies/enrich \
-H "X-API-KEY: $AUTOBOUND_API_KEY" \
-H "Content-Type: application/json" \
-d '{"domain":"insulet.com","signal_types":["sec-8k"],"limit":20}'Same industry
8-K at related companies
Questions about Insulet 8-K
When did Insulet file its latest 8-K?
What did Insulet disclose in its latest 8-K?
Where can I read Insulet's 8-K filing?
Source. Current reports (Form 8-K) filed with the SEC. Every card links to the filing on EDGAR.
Method. Insights are extracted from the filing text and grouped by category. Numbers are quoted from the filing.
Data as of .